Keyphrases
Clinical Trials
100%
Pregnancy Outcome
100%
Gaucher Disease
100%
Eliglustat
100%
Unintended Pregnancy
100%
During Pregnancy
33%
Healthy children
22%
Spontaneous Preterm Birth (sPTB)
22%
Phase II Trial
22%
Women of childbearing Potential
22%
Glucosidase
11%
Risk Reduction
11%
Exposure Time
11%
Enzymatic Activity
11%
Lysosomal Storage Disease
11%
Enzyme Replacement Therapy
11%
Contraception
11%
Ectopic Pregnancy
11%
Before Pregnancy
11%
Skeletal Manifestations
11%
Phase 1 Trial
11%
In Utero Death
11%
Elective Termination
11%
Metabolizer Status
11%
Pregnancy Test
11%
Glucosylceramide
11%
Hematological Manifestations
11%
Cytochrome P450 2D6 (CYP2D6)
11%
Pregnancy Complications
11%
Substrate Reduction Therapy
11%
Female Partners
11%
Four-phase
11%
Visceral Manifestation
11%
Medicine and Dentistry
Clinical Trial
100%
Gaucher Disease Type 1
100%
Eliglustat
100%
Spontaneous Abortion
22%
Clinician
11%
Glucosidase
11%
Enzyme Replacement Therapy
11%
Ectopic Pregnancy
11%
Substrate Reduction Therapy
11%
Contraceptive Behavior
11%
Pregnancy Test
11%
Enzyme Activity
11%
Storage Disease
11%
Glucosylceramide
11%
CYP2D6
11%
Lysosomal Storage Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Gaucher Disease Type 1
100%
Eliglustat
100%
Spontaneous Abortion
22%
Glucosidase
11%
Replacement Therapy
11%
Ectopic Pregnancy
11%
Storage Disease
11%
Lysosome Storage Disease
11%
Glucosylceramide
11%
CYP2D6
11%